Levur
Unlocking the next generation of oils, without the environmental impact
At a glance
-
Development stage
MVP developed
-
Investment stage
Pre-Seed
-
UNSW affiliation
Founders startup
-
Technology readiness level
TRL 4
-
Female led
Co-leadership
Levur will disrupt the unsustainable oil industry with its proprietary technology platform and IP, built by a proven team and validated through global customer engagement.
Direct substitutes to palm and other unsustainable oils through a proprietary technology platform.
Levur’s proprietary synthetic biology platform enables development of sustainable alternatives to environmentally-destructive oils, such as palm. Oils are molecularly-identical, commercially-viable, scalable and integrate seamlessly into existing supply chains, accelerating customer adoption. With its technology, strong IP and highly-skilled team Levur will disrupt the $60B+ palm oil market.
-
Levur’s proprietary synthetic biology platform enables rapid-development of molecularly-identical, commercially viable and scalable sustainable oils.
Global companies are actively seeking sustainable solutions to protect their businesses. Levur’s direct replacement oils enable manufacturers to switch to sustainable oil alternatives without cost-prohibitive changes to existing formulations, manufacturing facilities or supply chains.
Levur generates revenue through direct oil sales, long-term licensing contracts of its proprietary IP, and high-value project‑based development services for targeted customer applications.
-
- Palm oil is in 50% of grocery products and 70% of cosmetic products.
- $60B+ palm oil industry contributes to deforestation, biodiversity loss and 0.5 billion tonnes of Co2 emissions annually.
- Brands face regulatory and consumer pressure to find alternatives and meet demand. However, few viable drop-in replacements exist at scale.
-
- Global consumer product manufacturers dependent on palm‑derived oils
- Food ingredient and agribusiness companies (e.g. GrainCorp)
- Oleochemical producers
- Nutrition and specialty lipid companies
- Biofuel producers and distributors
-
- $1.2M pre-seed investment from Artesian GrainCorp Ventures and Main Sequence Ventures.
- Planned trials with GrainCorp and Unilever Global
- Signed contract with pharmaceutical company
Discover more UNSW spinouts
Search our catalogue of active spinouts and tech for license.